Yamamoto, M.; Shanmuganathan, M.; Hart, L.; Pai, N.; Britz-McKibbin, P.
Urinary Metabolites Enable Differential Diagnosis and Therapeutic Monitoring of Pediatric Inflammatory Bowel Disease. Metabolites 2021, 11, 245.
https://doi.org/10.3390/metabo11040245
AMA Style
Yamamoto M, Shanmuganathan M, Hart L, Pai N, Britz-McKibbin P.
Urinary Metabolites Enable Differential Diagnosis and Therapeutic Monitoring of Pediatric Inflammatory Bowel Disease. Metabolites. 2021; 11(4):245.
https://doi.org/10.3390/metabo11040245
Chicago/Turabian Style
Yamamoto, Mai, Meera Shanmuganathan, Lara Hart, Nikhil Pai, and Philip Britz-McKibbin.
2021. "Urinary Metabolites Enable Differential Diagnosis and Therapeutic Monitoring of Pediatric Inflammatory Bowel Disease" Metabolites 11, no. 4: 245.
https://doi.org/10.3390/metabo11040245
APA Style
Yamamoto, M., Shanmuganathan, M., Hart, L., Pai, N., & Britz-McKibbin, P.
(2021). Urinary Metabolites Enable Differential Diagnosis and Therapeutic Monitoring of Pediatric Inflammatory Bowel Disease. Metabolites, 11(4), 245.
https://doi.org/10.3390/metabo11040245